Biotech Announces
$17M in Financing
San Diego startup biotechnology company Genoptix Inc. said it raised $17 million in a Series B financing.
Tina Nova, founder and CEO of Genoptix, said the proceeds will be used to further develop the firm’s technology.
The company’s Optophoresis technology uses high-frequency near infrared laser light to analyze and isolate specific cells based on differences in their composition, size, shape, surface chemistry and environment, Genoptix said.
The technology potentially has wide applications, including tissue engineering, cell selection and stem cell isolation, according to published reports.
Alliance Technology Ventures led the financing, which included Enterprise Partners, Lotus Bioscience Investment Holdings, Mitsubishi Corp., Mitsubishi International Corp., Tullis-Dickerson & Co., Inc. and U.S. Trust’s Excelsior Venture Partners III, LLC, Genoptix stated in a release.
Genoptix was founded in Oct. 2000 and has 31 employees.
